Statin Therapy and Outcome After Ischemic Stroke
Danielle Ní Chróinín(Liverpool Hospital), Peter J. Kelly(University College Dublin), Fredrik Jönsson(Uppsala University Hospital), Exuperio Díez‐Tejedor(Hospital La Paz Institute for Health Research), Antonio Muscari(Uppsala University Hospital), Mario Di Napoli, Amanda G. Thrift(Monash Health), Joan Martí‐Fábregas(Hospital General Universitario de Albacete), Joan Montaner(Universitat Autònoma de Barcelona), Niamh Hannon(University College Dublin), Haralampos Milionis(University Hospital of Ioannina), Moira K. Kapral(University of Toronto), Sotirios Giannopoulos(National and Kapodistrian University of Athens), Natalia S. Rost(Harvard University), Stefan T. Engelter(University Hospital of Basel), Antonio M. Gotto(Cornell University), Slaven Pikija(Uppsala University Hospital), Signild Åsberg(Uppsala University), Jeffrey L. Probstfield(National Heart Lung and Blood Institute), Kjell Asplund(Umeå University), Elisa Cuadrado‐Godia(Universitat Autònoma de Barcelona), Konstantinos Vemmos(National and Kapodistrian University of Athens), Patricia Martínez‐Sánchez, Elizabeth Callaly(Eastern Health), Karen L. Furie(Brown University)
Cited by 239
Related Papers
K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification
|Data Archiving and Networked Services (DANS)|2002|11.7k
Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack
|Stroke|2014|5.2k
Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial
|The Lancet|2019|3.1k
K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease
|Data Archiving and Networked Services (DANS)|2003|2.5k